CentraCare

CentraCare, Rice Hospital Behavioral Health

In the 2025 National Directory of Mental Health Treatment Facilities. Intake 320-231-4390, 320-231-4399.

Type of Care

Mental health treatment (MH)

Service Setting

Hospital inpatient/24-hour hospital inpatient (HI); Outpatient (OP)

Facility Type

Psychiatric hospital (PSY)

Pharmacotherapies

Chlorpromazine (CHLOR); Droperidol (DROPE); Fluphenazine (FLUPH); Haloperidol (HALOP); Loxapine (LOXAP); Perphenazine (PERPH); Prochlorperazine (PROCH); Thiothixene (THIOT); Trifluoperazine (TRIFL); Aripiprazole (ARIPI); Asenapine (ASENA); Brexpiprazole (BREXP); Cariprazine (CARIP); Clozapine (CLOZA); IIoperidone (ILOPE); Lurasidone (LURAS); Olanzapine (OLANZ); Paliperidone (PALIP); Quetiapine (QUETI); Risperidone (RISPE); Ziprasidone (ZIPRA); Nicotine replacement (NRT); Antipsychotics used in treatment of SMI (ANTPYCH)

Treatment Approaches

Activity therapy (AT); Electroconvulsive therapy (ECT); Group therapy (GT); Individual psychotherapy (IPT); Telemedicine/telehealth therapy (TELE); Abnormal involuntary movement scale (AIMS)

Emergency Mental Health Services

Psychiatric emergency onsite services (PEON)

Facility Operation (e.g., Private, Public)

Private non-profit organization (PVTN)

Payment/Insurance/Funding Accepted

Medicare (MC); Medicaid (MD); Private health insurance (PI); Cash or self-payment (CASH); State-financed health insurance plan other than Medicaid (SI)

Assessment/Pre-treatment

Screening for tobacco use (STU)

Testing

Metabolic syndrome monitoring (MST); Laboratory testing (LABT)

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling (TCC)

Facility Smoking Policy

Smoking not permitted (SMON)

Age Groups Accepted

Young Adults (YAD); Seniors (SNR)

Facility Vaping Policy

Vaping not permitted (VAPN)